Protein and Vitamin D supplementation in Sarcopenia: A review
Abstrakt
RESEARCH OBJECTIVE: Perform a review of protein and vitamin D supplementation in Sarcopenia.
THE RESEARCH PROBLEM AND METHODS: Demographic change implies new demands for public health, with health promotion and prevention activities seeking to delay the appearance of common diseases in elderly population. We performed a review of protein and vitamin D supplementation in Sarcopenia.
THE PROCESS OF ARGUMENTATION: Changes in body composition occur during the aging process, resulting in increased body fat and reduced muscle mass and also bone mass. Sarcopenia is defined by a syndrome characterized by generalized and progressive loss of muscle mass and strength. After 50 years, there is a reduction between approximately 1% and 2% of muscle mass per year.
RESEARCH RESULTS: Currently progressive resistance training is the most well-established intervention, and dietary interventions such as protein and vitamin D also mentioned in literature. Leucine is a branched chain amino acid knows as key role in muscle protein synthesis. The consumption of leucine-enriched amino acids showed beneficial effects in the elderly contributing to the conservation of skeletal muscle mass. Vitamin D has pre-hormone functions, vitamin D deficiency is related with diffuse musculoskeletal pain, myopathy, sarcopenia and falls. Vitamin D supplementation of 800 to 1000 IU/day is associated with increased muscle strength in the elderly.
CONCLUSIONS, INNOVATIONS AND RECOMMENDATIONS: The protein and vitamin D supplementation are strategies that are proving to be important for the prevention and treatment of sarcopenia, especially when associated with resistance training.
Bibliografia
Achakzai, H., Shah, H., Zahid, SB., & Zuhaid, M. (2016). Hypovitaminosis-D: Frequency and association of clinical disease with biochemical levels in adult patients of RMI Medical OPD. Pakistan Journal of Medical Sciences, 32(2),
‑398.
Agergaard, J., Trostrup, J., Uth, J., Iversen, J.V., Boesen, A., Andersen, J.L. et al.
(2015). Does vitamin-D intake during resistance training improve the skeletal
muscle hypertrophic and strength response in young and elderly men? – a randomized controlled trial. Nutrition & Metabolism, 12(32), 015‑0029.
Ali, S. & Garcia, J.M. (2014). Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options – a mini-review. Gerontology, 60(4), 294‑305.
Anagnostis, P., Dimopoulou, C., Karras, S., Lambrinoudaki, I., & Goulis, D.G. (2015). Sarcopenia in post-menopausal women: Is there any role for vitamin D? Maturitas, 82(1), 56‑64.
Barbosa-Silva, T.G., Menezes, A.M., Bielemann, R.M., Malmstrom, T.K., & Gonzalez, M.C. (2016). Grupo de Estudos em Composição Corporal e Nutrição
(COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. Journal of American Medical Directions Association.
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A.J., Morley, J.E., Phillips, S., Sieber, C., Stehle, P., Teta, D., Visvanathan, R., Volpi, E. & Boirie, Y. (2012). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of American Medical Directions Association, 14(8), 542‑59.
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.Y., & Bruyère, O. (2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One, 12(1), e0169548.
Bischoff-Ferrari, H.A., Dawson-Hughes, B., Staehelin, H.B., Orav, J.E., Stuck, A.E., Theiler, R. et al. (2009). Fall prevention with supplemental and active forms
of vitamin D: a meta-analysis of randomised controlled trials. British Medical Journal, 1(339).
Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y. et al. (2004). Effect of Vitamin D on falls: a meta-
-analysis. Jama, 291(16), 1999‑2006.
Boirie, Y., Dangin, M., Gachon, P., Vasson, M.P., Maubois, J.L., & Beaufrere, B.
(1997). Slow and fast dietary proteins differently modulate postprandial protein accretion. Proceedings of the National Academy of Sciences of the United States of America, 94(26), 14930‑5.
Bolster, D.R., Vary, T.C., Kimball, S.R., & Jefferson, L.S. (2004). Leucine regulates translation initiation in rat skeletal muscle via enhanced eIF4G phosphorylation. Journal of Nutrition, 134(7), 1704‑10.
Brown, J.C., Harhay, M.O., & Harhay, M.N. (2015). Sarcopenia and mortality among a population-based sample of community-dwelling older adults. Journal
of Cachexia, Sarcopenia and Muscle, 15(10), 12073.
Budui, S.L., Rossi, A.P., & Zamboni, M. (2015). The pathogenetic bases of sarcopenia. Clinical Cases in Mineral and Bone Metabilism, 12(1), 22‑6.
Clark, B.C. & Manini, T.M. (2008). Sarcopenia =/= dynapenia. Journals of Gerontology. A Biological Sciences and Medical Sciences, 63(8), 829‑34.
Close, G.L., Hamilton, D.L., Philp, A., Burke, L.M., & Morton, J.P. (2016). New
strategies in sport nutrition to increase exercise performance. Free Radical Biology and Medicine, 5(16), 00030‑7.
Colonetti, T., Grande, A.J., Milton, K., Foster, C., Alexandre, M.C., Uggioni, M.L. & Rosa, M.I. (2017). Effects of whey protein supplement in the elderly submitted to resistance training: systematic review and meta-analysis. International Journal of Food Sciences and Nutrition, 68(3), 257‑264.
Cozzolino, S.M.F. (2016). Bioavailability of nutrients. 5. Ed. Barueri, SP: Manole.
Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, F.C., Michel, J.P., Rolland, Y., Schneider, S.M., Topinková, E., Vandewoude, M., & Zamboni, M. (2010). Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia
in Older People. Age Ageing, 39(4), 412‑2.
Devries, M.C. & Phillips, S.M. (2015). Supplemental protein in support of muscle
mass and health: advantage whey. Journal of Food Science, 80(1), A8-A15. Dickinson, J.M., Fry, C.S., Drummond, M.J., Gundermann, D.M., Walker, D.K.
& Glynn EL et al. (2011). Mammalian target of rapamycin complex 1 activation
is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. Journal of Nutrition, 141(5), 856‑62.
Dodds, R. & Sayer, A.A. (2014). Sarcopenia. Arquivos Brasileiros de Endocrinologia & Metabologia, 58(5), 464‑9.
Dorosty, A., Arero, G., Chamar, M., & Tavakoli, S. (2016). Prevalence of Sarcopenia and Its Association with Socioeconomic Status among the Elderly in
Tehran. Ethiopian Journal of Health Sciences, 26(4), 389‑96.
Drummond, M.J., Fry, C.S, Glynn, E.L., Dreyer, H.C., Dhanani, S., Timmerman,
K.L., Volpi, E., & Rasmussen, B.B. (2009). Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. The Journal of Physiology, 587(Pt 7), 1535‑46.
Ehninger, D., Neff, F., & Xie, K. (2014). Longevity, aging and rapamycin. Cellular and Molecular Life Sciences, 71(22), 4325‑46.
Evans, W.J., Morley, J.E., Argiles, J., Bales, C., Baracos, V., Guttridge, D., Jatoi,
A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., Marks, D., Mitch, W.E., Muscaritoli, M., Najand, A., Ponikowski, P., Rossi Fanelli, F., Schambelan, M.,
Schols, A., Schuster, M., Thomas, D., Wolfe, R., & Anker, S.D. (2008). Cachexia:
A new definition. Clinical Nutrition, 27, 793‑799.
Feng, X., Guo, T., Wang, Y., Kang, D., Che, X., & Zhang, H. et al. (2016). The vitamin D status and its effects on life quality among the elderly in Jinan, China. Archives of Gerontology and Geriatrics, 62, 26‑9.
Janssen, I., Baumgartner, R.N., Ross, R., Rosenberg, I.H., & Roubenoff, R. (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. American Journal of Epidemiology, 159(4), 413‑21.
Katsanos, C.S., Kobayashi, H., Sheffield-Moore, M., Aarsland, A., & Wolfe, R.R.
(2006). A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. American Journal of Physiology. Endocrinology and Metabolism, 291(2), 28.
Kim, J.S., Wilson, J.M., & Lee, S.R. (2010). Dietary implications on mechanisms
of sarcopenia: roles of protein, amino acids and antioxidants. The Journal of Nutritional Biochemistry, 21(1), 1‑13.
Landi, F., Calvani, R., Tosato, M., Martone, A.M., Ortolani, E., Savera, G. et al. (2016). Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence. Nutrients, 8(5).
Liu, C.J. & Latham, N.K. (2009). Progressive resistance strength training for improving physical function in older adults. The Cochrane Database of Systematic Reviews, 8(3).
Maeda, K. & Akagi, J. (2016). Cognitive impairment is independently associated
with definitive and possible sarcopenia in hospitalized older adults: The prevalence and impact of comorbidities. Geriatrics & Gerontology International,
(10), 12825.
Maeda, S.S., Borba, V.Z.C., Camargo, M.B.R., Silva, D.M.W., Borges, J.L., Cunha, Bandeira, F., & Lazaretti-Castro, M. (2014). Recommendations of the Brazilian Society of Endocrinology and Metabolism (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arquivos Brasileiros de Endocrinologia & Metabologia, 58(5), 411‑433.
Masanes, F., Culla, A., Navarro-Gonzalez, M., Navarro-Lopez, M., Sacanella, E.,
& Torres, B. et al. (2012). Prevalence of sarcopenia in healthy community-
-dwelling elderly in an urban area of Barcelona (Spain). The Journal of Nutrition
Health and Aging, 16(2), 184‑7.
Miljkovic, N., Lim, J.Y., Miljkovic, I., & Frontera, W.R. (2015). Aging of skeletal
muscle fibers. Annals of Rehabilitation Medicine, 39(2), 155‑62.
Muir S.W. & Montero-Odasso, M. (2011). Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. Journal of the American Geriatrics Society, 59(12), 2291‑300.
Nieuwenhuizen, W.F., Weenen, H., Rigby, P., & Hetherington, M.M. (2010). Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake. Clinical Nutrition, 29(2), 160‑9.
Nilwik, R., Snijders, T., Leenders, M., Groen, B.B., van Kranenburg, J., Verdijk,
L.B., & Van Loon, L.J. (2013). The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Experimental Gerontology, 48(5), 492‑8.
Paddon-Jones, D. & Rasmussen, B.B. (2009). Dietary protein recommendations
and the prevention of sarcopenia. Current Opinion in Clinical Nutrition and Metabolic Care, 12(1), 86‑90.
Pasiakos, S.M. (2012). Exercise and amino acid anabolic cell signaling and the regulation of skeletal muscle mass. Nutrients. 4(7), 740‑58.
Proud, C.G. (2004). mTOR-mediated regulation of translation factors by amino acids. Biochemical and Biophysical Research Communications, 313(2), 429‑36.
Ross, A.C., Manson, J.E., Abrams, A.S., Aloia, J.F., Brannon, P.M., Clinton, S.K., Durazo-Arvizu, R.A., Gallagher, J.C., Gallo, R.L., Jones, G. et al. (2011).
The report on dietary reference intakes for calcium and vitamin d from the institute of medicine: What clinicians need to know. The Journal of Clinical Endocrinology and Metabolism, 96(1), 53‑58.
Salles, J., Chanet, A., Giraudet, C., Patrac, V., Pierre, P., Jourdan, M., Luiking, Y.C., Verlaan, S., Migné, C., Boirie, Y., & Walrand, S. (2013). 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12
skeletal myotubes. Molecular Nutrition & Food Research, 57(12), 2137‑46.
Sato, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005). Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovascular Diseases, 20(3), 187‑92.
Tanner, S.B. & Harwell, S.A. (2015). More than healthy bones: a review of vitamin D in muscle health. Therapeutic Advances in Musculoskeletal Disease, 7(4), 152‑9.
Tarantino, U., Cannata, G., Lecce, D., Celi, M., Cerocchi, I., & Iundusi, R. (2007). Incidence of fragility fractures. Aging Clinical and Experimental Research, 19(4 Suppl), 7‑11.
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso-Mateos, J.L., Miret, M., Chatterji, S.et al. (2015). Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. Journal of Cachexia,
Sarcopenia and Muscle, 7(10), 12076.
Verlaan, S., Aspray, T.J., Bauer, J.M., Cederholm, T., Hemsworth, J., Hill, T.R. et al. (2015). Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study. Clinical Nutrition, 27(15), 00333‑7.
Volpi, E., Kobayashi, H., Sheffield-Moore, M., Mittendorfer, B., & Wolfe, R.R. (2003). Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. The American
Journal of Clinical Nutrition, 78(2), 250‑8.
Wilson, M.M. & Morley, J.E. (2003). Aging and energy balance. Journal of Applied Physiology, 95(4), 1728‑36.
Wolfe, R.R. & Miller, S.L. (1999). Amino acid availability controls muscle protein metabolism. Diabetes, Nutrition & Metabolism, 12(5), 322‑8.
Woo, J., Leung, J., & Morley, J.E. (2014). Validating the SARC-F: a suitable community screening tool for sarcopenia? Journal of the American Medical Directors Association, 15(9), 630‑4.
World Health Organization. (2015). World Report on Aging and Health. World Health Organization, Geneva.
Xu, Z.R., Tan, Z.J., Zhang, Q., Gui, Q.F., & Yang, Y.M. (2014). Clinical effectiveness of protein and amino acid supplementation on building muscle mass in elderly people: a meta-analysis. PLoS One, 9(9).
Yanai, H. (2015). Nutrition for Sarcopenia. Journal of Clinical Medicine Research, 7(12), 926‑31.
Copyright (c) 2018 Tamy Colonetti, Maria Ines Rosa
![Creative Commons License](http://i.creativecommons.org/l/by-nd/4.0/88x31.png)
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Bez utworów zależnych 4.0 Międzynarodowe.
Uwagi dotyczące praw autorskich
Autorzy publikujący w tym czasopiśmie wyrażają zgodę na następując warunki:
- Autorzy zachowują prawa autorskie, przyznając czasopismu prawo do pierwszej publikacji swojego tekstu jednocześnie zarejestrowanego pod numerem licencji CC BY-ND, która pozwala innym na korzystanie z tego tekstu z uznaniem autorstwa tekstu oraz pierwotnej publikacji w tym czasopiśmie.
- Autorzy proszeni są o nawiązywanie odrębnych, dodatkowych porozumień wynikających z umowy, dotyczących dystrybucji opublikowanej w czasopiśmie wersji tekstu nie na prawach wyłączności (np. opublikowanie go w repozytorium instytucji lub w innym czasopiśmie), z potwierdzeniem pierwszej publikacji w tym czasopiśmie.
Wyraża się zgodę i zachęca autorów do publikacji ich tekstu w Internecie (np. w repozytorium instytucji lub na jej stronie internetowej) przed lub podczas procesu składania tekstu jako, że może to prowadzić do korzystnych wymian oraz wcześniejszego i większego cytowania opublikowanego tekstu (Patrz The Effect of Open Access). Zalecamy wykorzystanie dowolnego portalu stowarzyszeń badawczych z niżej wymienionych: